Osaic Holdings’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$152K Buy
10,393
+1,348
+15% +$13K ﹤0.01% 4639
2026
Q1
$67.1K Sell
9,045
-242
-3% -$2.55K ﹤0.01% 4988
2025
Q4
$109K Buy
9,287
+4,193
+82% +$45.2K ﹤0.01% 4633
2025
Q3
$43.5K Buy
5,094
+166
+3% +$1.16K ﹤0.01% 5401
2025
Q2
$36.2K Buy
4,928
+111
+2% +$896 ﹤0.01% 5278
2025
Q1
$45.7K Sell
4,817
-1,345
-22% -$16.8K ﹤0.01% 4785
2024
Q4
$102K Sell
6,162
-1,278
-17% -$19.8K ﹤0.01% 4155
2024
Q3
$110K Sell
7,440
-675
-8% -$10.6K ﹤0.01% 4156
2024
Q2
$113K Sell
8,115
-6,135
-43% -$87K ﹤0.01% 4037
2024
Q1
$224K Sell
14,250
-29,589
-67% -$457K ﹤0.01% 3585
2023
Q4
$709K Buy
43,839
+12,333
+39% +$202K ﹤0.01% 2854
2023
Q3
$387K Buy
31,506
+5,529
+21% +$82.2K ﹤0.01% 3473
2023
Q2
$417K Sell
25,977
-21,505
-45% -$354K ﹤0.01% 3299
2023
Q1
$826K Buy
47,482
+26,846
+130% +$382K ﹤0.01% 2658
2022
Q4
$189K Sell
20,636
-2,592
-11% -$24.2K ﹤0.01% 3898
2022
Q3
$199K Sell
23,228
-1,582
-6% -$15.7K ﹤0.01% 3755
2022
Q2
$201K Buy
24,810
+4,941
+25% +$47.2K ﹤0.01% 3795
2022
Q1
$1.07M Sell
19,869
-2,881
-13% -$60.6K ﹤0.01% 2512
2021
Q4
$776K Sell
22,750
-2,298
-9% -$90K ﹤0.01% 2636
2021
Q3
$1.21M Sell
25,048
-3,621
-13% -$168K ﹤0.01% 2172
2021
Q2
$1.29M Buy
28,669
+7,694
+37% +$341K ﹤0.01% 2109
2021
Q1
$1.01M Sell
20,975
-35,050
-63% -$1.82M ﹤0.01% 2220
2020
Q4
$3.02M Sell
56,025
-18,045
-24% -$815K 0.01% 1152
2020
Q3
$2.43M Sell
74,070
-6,598
-8% -$245K 0.01% 1193
2020
Q2
$2.5M Sell
80,668
-16,611
-17% -$460K 0.01% 1113
2020
Q1
$2.61M Buy
+97,279
New +$2.91M 0.01% 918

Other funds holding NEO

Osaic Holdings's NEO Position: Q2 2026 in Review

Osaic Holdings increased its NeoGenomics (NEO) stake by 15% in Q2 2026, buying an estimated $13K and bringing the position to 10,393 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #4639.

Osaic Holdings first reported a position in NEO in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.02M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Osaic Holdings held 10,393 shares of NeoGenomics worth $152K as of Q2 2026.
  • Osaic Holdings bought 1,348 NeoGenomics shares in Q2 2026, an estimated $13K.
  • NeoGenomics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4639 holding.
  • Osaic Holdings first reported a position in NeoGenomics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's NeoGenomics position peaked at $3.02M in Q4 2020.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.